WHO Europe provided seed funding to develop the common ELSPAC methodology and to undertake pilots of the questionnaires in the UK, Russia and Greece. Subsequently, early funding for ALSPAC was obtained from various sources, including UK Government Departments, the UK Medical Research Council (MRC) and various charities such as the Wellcome Trust, British Heart Foundation, British Lung Foundation and Action Research among many others. North American funding was also obtained, including from several of the National Institutes of Health, and the March of Dimes. The University of Bristol has provided continual support for ALSPAC from soon after the onset of the study; since 2000, this support has been augmented by substantial strategic funding jointly from the Wellcome Trust and the MRC. Additional support for ALSPAC has come through programme and project grant funding from many sources,3 and is listed along with other study information on the ALSPAC website—http://www.bristol.ac.uk/alspac/.
